Form 8-K - Current report:
SEC Accession No. 0001104659-24-097781
Filing Date
2024-09-06
Accepted
2024-09-06 17:00:22
Documents
15
Period of Report
2024-09-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2423330d2_8k.htm   iXBRL 8-K 30665
2 EXHIBIT 1.1 tm2423330d2_ex1-1.htm EX-1.1 257696
3 EXHIBIT 5.1 tm2423330d2_ex5-1.htm EX-5.1 8903
  Complete submission text file 0001104659-24-097781.txt   539617

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ganx-20240906.xsd EX-101.SCH 3039
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20240906_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20240906_pre.xml EX-101.PRE 22375
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2423330d2_8k_htm.xml XML 3798
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 241285116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)